CDKN2B and precursor B-cell acute lymphoblastic leukemia: UnknownIKZF1 whole or intragenic deletion are underlying lesions in various B-ALL molecular subtypes Concomintant deletions in PAX5, CDKN2A, CDKN2B (homozygous) or PAR1 in absence of ERG deletion